- Home
- TASK vs PLSE Comparison
TASK vs PLSE Comparison
Compare TASK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TASK
- PLSE
- Stock Information
- Founded
- TASK 2008
- PLSE 2014
- Country
- TASK United States
- PLSE United States
- Employees
- TASK N/A
- PLSE N/A
- Industry
- TASK Retail: Computer Software & Peripheral Equipment
- PLSE Medical/Dental Instruments
- Sector
- TASK Technology
- PLSE Health Care
- Exchange
- TASK Nasdaq
- PLSE Nasdaq
- Market Cap
- TASK 1.5B
- PLSE 1.1B
- IPO Year
- TASK 2021
- PLSE 2016
- Fundamental
- Price
- TASK $17.59
- PLSE $16.27
- Analyst Decision
- TASK Buy
- PLSE Buy
- Analyst Count
- TASK 4
- PLSE 1
- Target Price
- TASK $16.88
- PLSE $22.00
- AVG Volume (30 Days)
- TASK 481.2K
- PLSE 178.1K
- Earning Date
- TASK 11-06-2025
- PLSE 10-29-2025
- Dividend Yield
- TASK N/A
- PLSE N/A
- EPS Growth
- TASK 21.25
- PLSE N/A
- EPS
- TASK 0.67
- PLSE N/A
- Revenue
- TASK $1,101,465,000.00
- PLSE N/A
- Revenue This Year
- TASK $19.10
- PLSE N/A
- Revenue Next Year
- TASK $11.73
- PLSE $700.00
- P/E Ratio
- TASK $25.99
- PLSE N/A
- Revenue Growth
- TASK 19.04
- PLSE N/A
- 52 Week Low
- TASK $10.57
- PLSE $13.77
- 52 Week High
- TASK $19.60
- PLSE $25.00
- Technical
- Relative Strength Index (RSI)
- TASK 54.05
- PLSE 56.35
- Support Level
- TASK $17.25
- PLSE $13.83
- Resistance Level
- TASK $17.56
- PLSE $16.80
- Average True Range (ATR)
- TASK 0.26
- PLSE 0.73
- MACD
- TASK -0.04
- PLSE 0.10
- Stochastic Oscillator
- TASK 40.30
- PLSE 82.15
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.